img

Global Intranasal Vaccine Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Intranasal Vaccine Market Insights, Forecast to 2034

Vaccines administered nasally
Global Intranasal Vaccine market is expected to reach to US$ 595 million in 2024, with a positive growth of %, compared with US$ 565 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Intranasal Vaccine industry is evaluated to reach US$ 797.4 million in 2029. The CAGR will be 5.0% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Intranasal Vaccine market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Intranasal Vaccine market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Sanofi
AstraZeneca
Abbott
GlaxoSmithKline
Serum Institute of India
Bharat Biotech
Antares Pharma
INJEX Pharma GmbH
BioDiem
PharmaJet and Crossject
Beijing Wantai Biopharmaceutical Co., Ltd.
Changchun Baike Company
Segment by Type
Flu Vaccine
COVID-19 Vaccines

Segment by Application


Hospital
Clinic

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Intranasal Vaccine plant distribution, commercial date of Intranasal Vaccine, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Intranasal Vaccine introduction, etc. Intranasal Vaccine Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Intranasal Vaccine
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Intranasal Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Intranasal Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Flu Vaccine
1.2.3 COVID-19 Vaccines
1.3 Market by Application
1.3.1 Global Intranasal Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Intranasal Vaccine Sales Estimates and Forecasts 2018-2029
2.2 Global Intranasal Vaccine Revenue by Region
2.2.1 Global Intranasal Vaccine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Intranasal Vaccine Revenue by Region (2018-2024)
2.2.3 Global Intranasal Vaccine Revenue by Region (2024-2029)
2.2.4 Global Intranasal Vaccine Revenue Market Share by Region (2018-2029)
2.3 Global Intranasal Vaccine Sales Estimates and Forecasts 2018-2029
2.4 Global Intranasal Vaccine Sales by Region
2.4.1 Global Intranasal Vaccine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Intranasal Vaccine Sales by Region (2018-2024)
2.4.3 Global Intranasal Vaccine Sales by Region (2024-2029)
2.4.4 Global Intranasal Vaccine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Intranasal Vaccine Sales by Manufacturers
3.1.1 Global Intranasal Vaccine Sales by Manufacturers (2018-2024)
3.1.2 Global Intranasal Vaccine Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Intranasal Vaccine in 2022
3.2 Global Intranasal Vaccine Revenue by Manufacturers
3.2.1 Global Intranasal Vaccine Revenue by Manufacturers (2018-2024)
3.2.2 Global Intranasal Vaccine Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Intranasal Vaccine Revenue in 2022
3.3 Global Key Players of Intranasal Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Intranasal Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Intranasal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Intranasal Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Intranasal Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Intranasal Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Intranasal Vaccine Sales by Type
4.1.1 Global Intranasal Vaccine Historical Sales by Type (2018-2024)
4.1.2 Global Intranasal Vaccine Forecasted Sales by Type (2024-2029)
4.1.3 Global Intranasal Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Intranasal Vaccine Revenue by Type
4.2.1 Global Intranasal Vaccine Historical Revenue by Type (2018-2024)
4.2.2 Global Intranasal Vaccine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Intranasal Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Intranasal Vaccine Price by Type
4.3.1 Global Intranasal Vaccine Price by Type (2018-2024)
4.3.2 Global Intranasal Vaccine Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Intranasal Vaccine Sales by Application
5.1.1 Global Intranasal Vaccine Historical Sales by Application (2018-2024)
5.1.2 Global Intranasal Vaccine Forecasted Sales by Application (2024-2029)
5.1.3 Global Intranasal Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Intranasal Vaccine Revenue by Application
5.2.1 Global Intranasal Vaccine Historical Revenue by Application (2018-2024)
5.2.2 Global Intranasal Vaccine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Intranasal Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Intranasal Vaccine Price by Application
5.3.1 Global Intranasal Vaccine Price by Application (2018-2024)
5.3.2 Global Intranasal Vaccine Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Intranasal Vaccine Market Size by Type
6.1.1 US & Canada Intranasal Vaccine Sales by Type (2018-2029)
6.1.2 US & Canada Intranasal Vaccine Revenue by Type (2018-2029)
6.2 US & Canada Intranasal Vaccine Market Size by Application
6.2.1 US & Canada Intranasal Vaccine Sales by Application (2018-2029)
6.2.2 US & Canada Intranasal Vaccine Revenue by Application (2018-2029)
6.3 US & Canada Intranasal Vaccine Market Size by Country
6.3.1 US & Canada Intranasal Vaccine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Intranasal Vaccine Sales by Country (2018-2029)
6.3.3 US & Canada Intranasal Vaccine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Intranasal Vaccine Market Size by Type
7.1.1 Europe Intranasal Vaccine Sales by Type (2018-2029)
7.1.2 Europe Intranasal Vaccine Revenue by Type (2018-2029)
7.2 Europe Intranasal Vaccine Market Size by Application
7.2.1 Europe Intranasal Vaccine Sales by Application (2018-2029)
7.2.2 Europe Intranasal Vaccine Revenue by Application (2018-2029)
7.3 Europe Intranasal Vaccine Market Size by Country
7.3.1 Europe Intranasal Vaccine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Intranasal Vaccine Sales by Country (2018-2029)
7.3.3 Europe Intranasal Vaccine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Intranasal Vaccine Market Size
8.1.1 China Intranasal Vaccine Sales (2018-2029)
8.1.2 China Intranasal Vaccine Revenue (2018-2029)
8.2 China Intranasal Vaccine Market Size by Application
8.2.1 China Intranasal Vaccine Sales by Application (2018-2029)
8.2.2 China Intranasal Vaccine Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Intranasal Vaccine Market Size by Type
9.1.1 Asia Intranasal Vaccine Sales by Type (2018-2029)
9.1.2 Asia Intranasal Vaccine Revenue by Type (2018-2029)
9.2 Asia Intranasal Vaccine Market Size by Application
9.2.1 Asia Intranasal Vaccine Sales by Application (2018-2029)
9.2.2 Asia Intranasal Vaccine Revenue by Application (2018-2029)
9.3 Asia Intranasal Vaccine Sales by Region
9.3.1 Asia Intranasal Vaccine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Intranasal Vaccine Revenue by Region (2018-2029)
9.3.3 Asia Intranasal Vaccine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Intranasal Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Intranasal Vaccine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Intranasal Vaccine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Intranasal Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Intranasal Vaccine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Intranasal Vaccine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Intranasal Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Intranasal Vaccine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Intranasal Vaccine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Intranasal Vaccine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Intranasal Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Sanofi Intranasal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Information
11.2.2 AstraZeneca Overview
11.2.3 AstraZeneca Intranasal Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 AstraZeneca Intranasal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AstraZeneca Recent Developments
11.3 Abbott
11.3.1 Abbott Company Information
11.3.2 Abbott Overview
11.3.3 Abbott Intranasal Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Abbott Intranasal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Abbott Recent Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Information
11.4.2 GlaxoSmithKline Overview
11.4.3 GlaxoSmithKline Intranasal Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 GlaxoSmithKline Intranasal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 GlaxoSmithKline Recent Developments
11.5 Serum Institute of India
11.5.1 Serum Institute of India Company Information
11.5.2 Serum Institute of India Overview
11.5.3 Serum Institute of India Intranasal Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Serum Institute of India Intranasal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Serum Institute of India Recent Developments
11.6 Bharat Biotech
11.6.1 Bharat Biotech Company Information
11.6.2 Bharat Biotech Overview
11.6.3 Bharat Biotech Intranasal Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Bharat Biotech Intranasal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bharat Biotech Recent Developments
11.7 Antares Pharma
11.7.1 Antares Pharma Company Information
11.7.2 Antares Pharma Overview
11.7.3 Antares Pharma Intranasal Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Antares Pharma Intranasal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Antares Pharma Recent Developments
11.8 INJEX Pharma GmbH
11.8.1 INJEX Pharma GmbH Company Information
11.8.2 INJEX Pharma GmbH Overview
11.8.3 INJEX Pharma GmbH Intranasal Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 INJEX Pharma GmbH Intranasal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 INJEX Pharma GmbH Recent Developments
11.9 BioDiem
11.9.1 BioDiem Company Information
11.9.2 BioDiem Overview
11.9.3 BioDiem Intranasal Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 BioDiem Intranasal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 BioDiem Recent Developments
11.10 PharmaJet and Crossject
11.10.1 PharmaJet and Crossject Company Information
11.10.2 PharmaJet and Crossject Overview
11.10.3 PharmaJet and Crossject Intranasal Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 PharmaJet and Crossject Intranasal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 PharmaJet and Crossject Recent Developments
11.11 Beijing Wantai Biopharmaceutical Co., Ltd.
11.11.1 Beijing Wantai Biopharmaceutical Co., Ltd. Company Information
11.11.2 Beijing Wantai Biopharmaceutical Co., Ltd. Overview
11.11.3 Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Beijing Wantai Biopharmaceutical Co., Ltd. Recent Developments
11.12 Changchun Baike Company
11.12.1 Changchun Baike Company Company Information
11.12.2 Changchun Baike Company Overview
11.12.3 Changchun Baike Company Intranasal Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Changchun Baike Company Intranasal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Changchun Baike Company Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Intranasal Vaccine Industry Chain Analysis
12.2 Intranasal Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Intranasal Vaccine Production Mode & Process
12.4 Intranasal Vaccine Sales and Marketing
12.4.1 Intranasal Vaccine Sales Channels
12.4.2 Intranasal Vaccine Distributors
12.5 Intranasal Vaccine Customers
13 Market Dynamics
13.1 Intranasal Vaccine Industry Trends
13.2 Intranasal Vaccine Market Drivers
13.3 Intranasal Vaccine Market Challenges
13.4 Intranasal Vaccine Market Restraints
14 Key Findings in The Global Intranasal Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Intranasal Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Flu Vaccine
Table 3. Major Manufacturers of COVID-19 Vaccines
Table 4. Global Intranasal Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Intranasal Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Intranasal Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Intranasal Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Intranasal Vaccine Revenue Market Share by Region (2018-2024)
Table 9. Global Intranasal Vaccine Revenue Market Share by Region (2024-2029)
Table 10. Global Intranasal Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Intranasal Vaccine Sales by Region (2018-2024) & (K Units)
Table 12. Global Intranasal Vaccine Sales by Region (2024-2029) & (K Units)
Table 13. Global Intranasal Vaccine Sales Market Share by Region (2018-2024)
Table 14. Global Intranasal Vaccine Sales Market Share by Region (2024-2029)
Table 15. Global Intranasal Vaccine Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Intranasal Vaccine Sales Share by Manufacturers (2018-2024)
Table 17. Global Intranasal Vaccine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Intranasal Vaccine Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Intranasal Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Intranasal Vaccine Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Intranasal Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Intranasal Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intranasal Vaccine as of 2022)
Table 23. Global Key Manufacturers of Intranasal Vaccine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Intranasal Vaccine, Product Offered and Application
Table 25. Global Key Manufacturers of Intranasal Vaccine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Intranasal Vaccine Sales by Type (2018-2024) & (K Units)
Table 28. Global Intranasal Vaccine Sales by Type (2024-2029) & (K Units)
Table 29. Global Intranasal Vaccine Sales Share by Type (2018-2024)
Table 30. Global Intranasal Vaccine Sales Share by Type (2024-2029)
Table 31. Global Intranasal Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Intranasal Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Intranasal Vaccine Revenue Share by Type (2018-2024)
Table 34. Global Intranasal Vaccine Revenue Share by Type (2024-2029)
Table 35. Intranasal Vaccine Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Intranasal Vaccine Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Intranasal Vaccine Sales by Application (2018-2024) & (K Units)
Table 38. Global Intranasal Vaccine Sales by Application (2024-2029) & (K Units)
Table 39. Global Intranasal Vaccine Sales Share by Application (2018-2024)
Table 40. Global Intranasal Vaccine Sales Share by Application (2024-2029)
Table 41. Global Intranasal Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Intranasal Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Intranasal Vaccine Revenue Share by Application (2018-2024)
Table 44. Global Intranasal Vaccine Revenue Share by Application (2024-2029)
Table 45. Intranasal Vaccine Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Intranasal Vaccine Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Intranasal Vaccine Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Intranasal Vaccine Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Intranasal Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Intranasal Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Intranasal Vaccine Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Intranasal Vaccine Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Intranasal Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Intranasal Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Intranasal Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Intranasal Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Intranasal Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Intranasal Vaccine Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Intranasal Vaccine Sales by Country (2024-2029) & (K Units)
Table 60. Europe Intranasal Vaccine Sales by Type (2018-2024) & (K Units)
Table 61. Europe Intranasal Vaccine Sales by Type (2024-2029) & (K Units)
Table 62. Europe Intranasal Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Intranasal Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Intranasal Vaccine Sales by Application (2018-2024) & (K Units)
Table 65. Europe Intranasal Vaccine Sales by Application (2024-2029) & (K Units)
Table 66. Europe Intranasal Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Intranasal Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Intranasal Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Intranasal Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Intranasal Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Intranasal Vaccine Sales by Country (2018-2024) & (K Units)
Table 72. Europe Intranasal Vaccine Sales by Country (2024-2029) & (K Units)
Table 73. China Intranasal Vaccine Sales by Type (2018-2024) & (K Units)
Table 74. China Intranasal Vaccine Sales by Type (2024-2029) & (K Units)
Table 75. China Intranasal Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Intranasal Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Intranasal Vaccine Sales by Application (2018-2024) & (K Units)
Table 78. China Intranasal Vaccine Sales by Application (2024-2029) & (K Units)
Table 79. China Intranasal Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Intranasal Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Intranasal Vaccine Sales by Type (2018-2024) & (K Units)
Table 82. Asia Intranasal Vaccine Sales by Type (2024-2029) & (K Units)
Table 83. Asia Intranasal Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Intranasal Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Intranasal Vaccine Sales by Application (2018-2024) & (K Units)
Table 86. Asia Intranasal Vaccine Sales by Application (2024-2029) & (K Units)
Table 87. Asia Intranasal Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Intranasal Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Intranasal Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Intranasal Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Intranasal Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Intranasal Vaccine Sales by Region (2018-2024) & (K Units)
Table 93. Asia Intranasal Vaccine Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Intranasal Vaccine Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Intranasal Vaccine Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Intranasal Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Intranasal Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Intranasal Vaccine Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Intranasal Vaccine Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Intranasal Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Intranasal Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Intranasal Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Intranasal Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Intranasal Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Intranasal Vaccine Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Intranasal Vaccine Sales by Country (2024-2029) & (K Units)
Table 107. Sanofi Company Information
Table 108. Sanofi Description and Major Businesses
Table 109. Sanofi Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Sanofi Intranasal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Sanofi Recent Developments
Table 112. AstraZeneca Company Information
Table 113. AstraZeneca Description and Major Businesses
Table 114. AstraZeneca Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. AstraZeneca Intranasal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. AstraZeneca Recent Developments
Table 117. Abbott Company Information
Table 118. Abbott Description and Major Businesses
Table 119. Abbott Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Abbott Intranasal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Abbott Recent Developments
Table 122. GlaxoSmithKline Company Information
Table 123. GlaxoSmithKline Description and Major Businesses
Table 124. GlaxoSmithKline Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. GlaxoSmithKline Intranasal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. GlaxoSmithKline Recent Developments
Table 127. Serum Institute of India Company Information
Table 128. Serum Institute of India Description and Major Businesses
Table 129. Serum Institute of India Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Serum Institute of India Intranasal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Serum Institute of India Recent Developments
Table 132. Bharat Biotech Company Information
Table 133. Bharat Biotech Description and Major Businesses
Table 134. Bharat Biotech Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Bharat Biotech Intranasal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Bharat Biotech Recent Developments
Table 137. Antares Pharma Company Information
Table 138. Antares Pharma Description and Major Businesses
Table 139. Antares Pharma Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Antares Pharma Intranasal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Antares Pharma Recent Developments
Table 142. INJEX Pharma GmbH Company Information
Table 143. INJEX Pharma GmbH Description and Major Businesses
Table 144. INJEX Pharma GmbH Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. INJEX Pharma GmbH Intranasal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. INJEX Pharma GmbH Recent Developments
Table 147. BioDiem Company Information
Table 148. BioDiem Description and Major Businesses
Table 149. BioDiem Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. BioDiem Intranasal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. BioDiem Recent Developments
Table 152. PharmaJet and Crossject Company Information
Table 153. PharmaJet and Crossject Description and Major Businesses
Table 154. PharmaJet and Crossject Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. PharmaJet and Crossject Intranasal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. PharmaJet and Crossject Recent Developments
Table 157. Beijing Wantai Biopharmaceutical Co., Ltd. Company Information
Table 158. Beijing Wantai Biopharmaceutical Co., Ltd. Description and Major Businesses
Table 159. Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Beijing Wantai Biopharmaceutical Co., Ltd. Intranasal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Beijing Wantai Biopharmaceutical Co., Ltd. Recent Developments
Table 162. Changchun Baike Company Company Information
Table 163. Changchun Baike Company Description and Major Businesses
Table 164. Changchun Baike Company Intranasal Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Changchun Baike Company Intranasal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Changchun Baike Company Recent Developments
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Intranasal Vaccine Distributors List
Table 170. Intranasal Vaccine Customers List
Table 171. Intranasal Vaccine Market Trends
Table 172. Intranasal Vaccine Market Drivers
Table 173. Intranasal Vaccine Market Challenges
Table 174. Intranasal Vaccine Market Restraints
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Intranasal Vaccine Product Picture
Figure 2. Global Intranasal Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Intranasal Vaccine Market Share by Type in 2022 & 2029
Figure 4. Flu Vaccine Product Picture
Figure 5. COVID-19 Vaccines Product Picture
Figure 6. Global Intranasal Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Intranasal Vaccine Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Intranasal Vaccine Report Years Considered
Figure 11. Global Intranasal Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Intranasal Vaccine Revenue 2018-2029 (US$ Million)
Figure 13. Global Intranasal Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Intranasal Vaccine Revenue Market Share by Region (2018-2029)
Figure 15. Global Intranasal Vaccine Sales 2018-2029 ((K Units)
Figure 16. Global Intranasal Vaccine Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Intranasal Vaccine Sales YoY (2018-2029) & (K Units)
Figure 18. US & Canada Intranasal Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Intranasal Vaccine Sales YoY (2018-2029) & (K Units)
Figure 20. Europe Intranasal Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Intranasal Vaccine Sales YoY (2018-2029) & (K Units)
Figure 22. China Intranasal Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Intranasal Vaccine Sales YoY (2018-2029) & (K Units)
Figure 24. Asia (excluding China) Intranasal Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Intranasal Vaccine Sales YoY (2018-2029) & (K Units)
Figure 26. Middle East, Africa and Latin America Intranasal Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Intranasal Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Intranasal Vaccine in the World: Market Share by Intranasal Vaccine Revenue in 2022
Figure 29. Global Intranasal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Intranasal Vaccine Sales Market Share by Type (2018-2029)
Figure 31. Global Intranasal Vaccine Revenue Market Share by Type (2018-2029)
Figure 32. Global Intranasal Vaccine Sales Market Share by Application (2018-2029)
Figure 33. Global Intranasal Vaccine Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Intranasal Vaccine Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Intranasal Vaccine Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Intranasal Vaccine Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Intranasal Vaccine Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Intranasal Vaccine Revenue Share by Country (2018-2029)
Figure 39. US & Canada Intranasal Vaccine Sales Share by Country (2018-2029)
Figure 40. U.S. Intranasal Vaccine Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Intranasal Vaccine Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Intranasal Vaccine Sales Market Share by Type (2018-2029)
Figure 43. Europe Intranasal Vaccine Revenue Market Share by Type (2018-2029)
Figure 44. Europe Intranasal Vaccine Sales Market Share by Application (2018-2029)
Figure 45. Europe Intranasal Vaccine Revenue Market Share by Application (2018-2029)
Figure 46. Europe Intranasal Vaccine Revenue Share by Country (2018-2029)
Figure 47. Europe Intranasal Vaccine Sales Share by Country (2018-2029)
Figure 48. Germany Intranasal Vaccine Revenue (2018-2029) & (US$ Million)
Figure 49. France Intranasal Vaccine Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Intranasal Vaccine Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Intranasal Vaccine Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Intranasal Vaccine Revenue (2018-2029) & (US$ Million)
Figure 53. China Intranasal Vaccine Sales Market Share by Type (2018-2029)
Figure 54. China Intranasal Vaccine Revenue Market Share by Type (2018-2029)
Figure 55. China Intranasal Vaccine Sales Market Share by Application (2018-2029)
Figure 56. China Intranasal Vaccine Revenue Market Share by Application (2018-2029)
Figure 57. Asia Intranasal Vaccine Sales Market Share by Type (2018-2029)
Figure 58. Asia Intranasal Vaccine Revenue Market Share by Type (2018-2029)
Figure 59. Asia Intranasal Vaccine Sales Market Share by Application (2018-2029)
Figure 60. Asia Intranasal Vaccine Revenue Market Share by Application (2018-2029)
Figure 61. Asia Intranasal Vaccine Revenue Share by Region (2018-2029)
Figure 62. Asia Intranasal Vaccine Sales Share by Region (2018-2029)
Figure 63. Japan Intranasal Vaccine Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Intranasal Vaccine Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Intranasal Vaccine Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Intranasal Vaccine Revenue (2018-2029) & (US$ Million)
Figure 67. India Intranasal Vaccine Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Intranasal Vaccine Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Intranasal Vaccine Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Intranasal Vaccine Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Intranasal Vaccine Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Intranasal Vaccine Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Intranasal Vaccine Sales Share by Country (2018-2029)
Figure 74. Brazil Intranasal Vaccine Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Intranasal Vaccine Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Intranasal Vaccine Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Intranasal Vaccine Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Intranasal Vaccine Revenue (2018-2029) & (US$ Million)
Figure 79. Intranasal Vaccine Value Chain
Figure 80. Intranasal Vaccine Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries